Bear Market Rally Spurs Biotech Stocks: A Primer on Tariffs…Update-3…Pivot Day Confirmed
Update-3 ...ABBVIE (ABBV) beat with adj. EPS 2.46 earnings and revenues of $13.343B an increase of 4%,but tariff issues lurking., but I$10M investments will be made in U.S. Strong sales $6.264B of new immunology drugs Rinvoq and Skirizi an increase of 16.6%. EPS guidance raised too...
Healthcare Sector Update: MEDtech and Diagnostics…UPDATE-2 …XBI green along with SMID biotechs!
Update-2 4/21/25...11a EDT..XBI trying to bounce in mid 70s up 1% at $76 handle. SMID biotech movers: EYPT RYTM RZLT WVE GPCR etc. Update-1 4/17/25--UNH shares crash over 20% on earnings release due to higher medical costs. Unbelievable surprise because this was supposed to be the most...
Healthcare Sector Update…..coming at end of the day 4/16/25
Amidst the tariff chaos we may get clues from one of the most defensive sectors of the market-healthcare stocks. Recently we provided a playbook of positions for those actively managing their LIFE SCIENCE portfolios. However in the midst of tariff chaos and policies targeting various...
Is it a Good Time to Trade Small Cap Biotech Stocks?– 3 Steps to Consider…Update-3 …How do NIH cutbacks affect ongoing clinical trials?
UPDATE 4/15/25: Nice Rally in SMID BiOTECH on Monday then faded. UPDATE tomorrow with UNH Congress needs to do their job and prioritize cancer research funding especially for clinical trials. Update-3 4/13...We will summarize market performance for healthcare and biotech on our next update: XLV...
Hell Week in March 2025: Detoxing with Tariffs until April 2? Update-4…No Liberation from new BEAR today as of 4/4 11a
Update-4 4/6/25 ...Signposts at end of Hell Week, here are values: XLV at 135.28...down 6.39% week ,1.66% YTD, IBB at $117.16 down 10.08% week, 11.38% YTD, XBI at $73.66 down 12.73% % week, 18.21% YTD. DOW down 9.9% YTD, NASDAQ 100 down 17.2% YTD, S&P 500 down 13.7% YTD. ===========...